{
    "clinical_study": {
        "@rank": "127838", 
        "arm_group": {
            "arm_group_label": "Lysine Amino Acid", 
            "arm_group_type": "Experimental", 
            "description": "29, 37, 46 and 54% of the mean Lysine requirement of 35 mg/kg/d will be given to subjects."
        }, 
        "brief_summary": {
            "textblock": "Our objective is to determine the metabolic availability of Lysine  in white maize using the\n      indicator amino acid oxidation (IAAO) technique."
        }, 
        "brief_title": "Metabolic Availability of Lysine From White Maize", 
        "completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Lysine Bioavailability in White Corn Determined in Healthy Young Adult Men", 
        "detailed_description": {
            "textblock": "Our objective is to determine the metabolic availability of Lysine  in white maize. 7 young,\n      healthy, male adults will receive graded levels (29, 37,46 and 54%) of lysine requirement of\n      35 mg/kg/d as a crystalline AA mixture and a porridge of white cornmeal protein\n      respectively."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy Adult males (20-49 years old)\n\n        Exclusion Criteria:\n\n          -  A history of recent weight loss or illness\n\n          -  Use of any medication at the time of entry into the study"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "49 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "7", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 17, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02018575", 
            "org_study_id": "0019850580 amendment"
        }, 
        "intervention": [
            {
                "arm_group_label": "Lysine Amino Acid", 
                "description": "Crystaline Lysine from Amino Acid Mixture in amount of 29, 37, 46 and 54% of the mean Lysine requirement of 35 mg/kg/d will be given to subjects.", 
                "intervention_name": "Crystaline Lysine from Amino Acid Mixture", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Lysine Amino Acid", 
                "description": "A cornmeal porrodge including 29, 37, 46 and 54% of the mean Lysine requirement of 35 mg/kg/d will be given to subjects.", 
                "intervention_name": "White cornmeal porridge", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Lysine", 
            "White corn", 
            "Bioavailability", 
            "Amino acids"
        ], 
        "lastchanged_date": "December 23, 2013", 
        "location": {
            "contact": {
                "email": "nazanin.noori@sickkids.ca", 
                "last_name": "Nazanin Noori, MD, PhD", 
                "phone": "4168137454"
            }, 
            "contact_backup": {
                "email": "mahroukh.rafii@sickkids.ca", 
                "last_name": "Mahroukh Rafii, BSc", 
                "phone": "4168137454"
            }, 
            "facility": {
                "address": {
                    "city": "Toronto", 
                    "country": "Canada", 
                    "state": "Ontario", 
                    "zip": "M5G-1X8"
                }, 
                "name": "The Hospital for Sick Children"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "1", 
        "official_title": "Application of the Indicator Amino Acid Oxidation Technique for the Determination of Metabolic Availability of Lysine From White Maize Protein, in Young Adult Men", 
        "other_outcome": [
            {
                "description": "3 breath samples will be taken to provide a baseline F13CO2 measurement (Level of Phenylalanine oxidation). Breath samples will be collected and analyzed for 13CO2 enrichment.", 
                "measure": "Metabolic availability of Lysine", 
                "safety_issue": "No", 
                "time_frame": "30 mins after intake of the fourth hourly meal (before tracer infusion)"
            }, 
            {
                "description": "3 breath samples will be taken to provide a baseline F13CO2 measurement (Level of Phenylalanine oxidation). Breath samples will be collected and analyzed for 13CO2 enrichment.", 
                "measure": "Metabolic Availability of Lysine", 
                "safety_issue": "No", 
                "time_frame": "45 mins after intake of the fourth hourly meal (before tracer infusion)"
            }, 
            {
                "description": "4 breath samples will be taken to provide F13CO2 measurement (Level of Phenylalanine oxidation). Breath samples will be collected and analyzed for 13CO2 enrichment.", 
                "measure": "Metabolic Availability of Lysine", 
                "safety_issue": "No", 
                "time_frame": "Post Tracer Infusion (between 150 and 240 min of tracer infusion)"
            }
        ], 
        "overall_contact": {
            "email": "nazanin.noori@sickkids.ca", 
            "last_name": "Nazanin Noori, MD, PhD", 
            "phone": "4168137454"
        }, 
        "overall_official": {
            "affiliation": "The Hospital for Sick Children, Toronto, Canada", 
            "last_name": "Paul B Pencharz, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Canada: Ethics Review Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "3 breath samples will be taken to provide a baseline F13CO2 measurement (Level of Phenylalanine oxidation). Breath samples will be collected and analyzed for 13CO2 enrichment.", 
            "measure": "Metabolic Availability of Lysine", 
            "safety_issue": "No", 
            "time_frame": "Baseline"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02018575"
        }, 
        "responsible_party": {
            "investigator_affiliation": "The Hospital for Sick Children", 
            "investigator_full_name": "Dr. Paul Pencharz", 
            "investigator_title": "Professor of Paediatrics and Nutritional Sciences (Emeritus) University of Toronto, Senior Scientist Research Institute, The Hospital for Sick Children", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "3 breath samples will be taken to provide a baseline F13CO2 measurement (Level of Phenylalanine oxidation). Breath samples will be collected and analyzed for 13CO2 enrichment.", 
            "measure": "Metabolic Availability of Lysine", 
            "safety_issue": "No", 
            "time_frame": "15 mins after intake of the fourth hourly meal (before tracer infusion)"
        }, 
        "source": "The Hospital for Sick Children", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "The Hospital for Sick Children", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Bio-availability Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Health Services Research", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}